OTCMKTS:CGNH - CardioGenics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0107 0.00 (0.00 %)
(As of 12/10/2018 04:00 PM ET)
Previous Close$0.0107
Today's Range$0.0056 - $0.0107
52-Week Range$0.0050 - $0.0330
Volume43,087 shs
Average Volume14,633 shs
Market Capitalization$1.03 million
P/E RatioN/A
Dividend YieldN/A
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Receive CGNH News and Ratings via Email

Sign-up to receive the latest news and ratings for CGNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Business services, not elsewhere classified
Current SymbolOTCMKTS:CGNH
Previous Symbol


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares96,050,000
Market Cap$1.03 million
OptionableNot Optionable

CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions

What is CardioGenics' stock symbol?

CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."

Has CardioGenics been receiving favorable news coverage?

Press coverage about CGNH stock has been trending very positive on Monday, according to InfoTrie. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CardioGenics earned a news impact score of 3.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days.

Who are some of CardioGenics' key competitors?

Who are CardioGenics' key executives?

CardioGenics' management team includes the folowing people:
  • Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 60)
  • Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 69)
  • Ms. Linda J. Stering F.Inst.L.C.O., Sec. & Director (Age 57)

How do I buy shares of CardioGenics?

Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CardioGenics' stock price today?

One share of CGNH stock can currently be purchased for approximately $0.0107.

How big of a company is CardioGenics?

CardioGenics has a market capitalization of $1.03 million.

What is CardioGenics' official website?

The official website for CardioGenics is http://www.cardiogenics.com.

How can I contact CardioGenics?

CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]

MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  70
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel